Barreto JN - Search Results

1

A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukaemia patients during chemotherapy-induced neutropenia.

Yemm KE, Barreto JN, Mara KC, Dierkhising RA, Gangat N, Tosh PK. Yemm KE, et al. Among authors: barreto jn. J Antimicrob Chemother. 2018 Jan 1;73(1):204-211. doi: 10.1093/jac/dkx338. J Antimicrob Chemother. 2018. PMID: 29040595

2

Characterization of bacterial infections in allogeneic hematopoietic stem cell transplant recipients who received prophylactic levofloxacin with either penicillin or doxycycline.

Therriault BL, Wilson JW, Barreto JN, Estes LL. Therriault BL, et al. Among authors: barreto jn. Mayo Clin Proc. 2010 Aug;85(8):711-8. doi: 10.4065/mcp.2010.0006. Mayo Clin Proc. 2010. PMID: 20675508 Free PMC article.

3

The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.

Barreto JN, Beach CL, Wolf RC, Merten JA, Tosh PK, Wilson JW, Hogan WJ, Litzow MR. Barreto JN, et al. Am J Hematol. 2013 Apr;88(4):283-8. doi: 10.1002/ajh.23388. Epub 2013 Mar 5. Am J Hematol. 2013. PMID: 23460251 Free article.

4

Cefpodoxime for antimicrobial prophylaxis in neutropenia: a retrospective case series.

Wojenski DJ, Barreto JN, Wolf RC, Tosh PK. Wojenski DJ, et al. Among authors: barreto jn. Clin Ther. 2014 Jun 1;36(6):976-81. doi: 10.1016/j.clinthera.2014.04.013. Epub 2014 May 13. Clin Ther. 2014. PMID: 24832560

5

Rothia bacteremia: a 10-year experience at Mayo Clinic, Rochester, Minnesota.

Ramanan P, Barreto JN, Osmon DR, Tosh PK. Ramanan P, et al. Among authors: barreto jn. J Clin Microbiol. 2014 Sep;52(9):3184-9. doi: 10.1128/JCM.01270-14. Epub 2014 Jun 20. J Clin Microbiol. 2014. PMID: 24951810 Free PMC article.

6

Supratherapeutic international normalized ratios in warfarin-treated patients who receive a highly potentiating antimicrobial course.

Daniels LM, Barreto JN, Tosh PK. Daniels LM, et al. Among authors: barreto jn. JAMA Intern Med. 2014 Jul;174(7):1200. doi: 10.1001/jamainternmed.2014.1615. JAMA Intern Med. 2014. PMID: 25003887 No abstract available.

7

Serum peak sulfamethoxazole concentrations demonstrate difficulty in achieving a target range: a retrospective cohort study.

Dao BD, Barreto JN, Wolf RC, Dierkhising RA, Plevak MF, Tosh PK. Dao BD, et al. Among authors: barreto jn. Curr Ther Res Clin Exp. 2014 Nov 11;76:104-9. doi: 10.1016/j.curtheres.2014.08.003. eCollection 2014 Dec. Curr Ther Res Clin Exp. 2014. PMID: 25408788 Free PMC article.

8

Emerging issues in gram-negative bacterial resistance: an update for the practicing clinician.

Vasoo S, Barreto JN, Tosh PK. Vasoo S, et al. Among authors: barreto jn. Mayo Clin Proc. 2015 Mar;90(3):395-403. doi: 10.1016/j.mayocp.2014.12.002. Mayo Clin Proc. 2015. PMID: 25744116 Review.

9

Retrospective Comparison of Posaconazole Levels in Patients Taking the Delayed-Release Tablet versus the Oral Suspension.

Durani U, Tosh PK, Barreto JN, Estes LL, Jannetto PJ, Tande AJ. Durani U, et al. Among authors: barreto jn. Antimicrob Agents Chemother. 2015 Aug;59(8):4914-8. doi: 10.1128/AAC.00496-15. Epub 2015 Jun 8. Antimicrob Agents Chemother. 2015. PMID: 26055378 Free PMC article.

10

Failure mode and effects analysis to reduce risk of anticoagulation levels above the target range during concurrent antimicrobial therapy.

Daniels LM, Barreto JN, Kuth JC, Anderson JR, Zhang B, Majka AJ, Morgenthaler TI, Tosh PK. Daniels LM, et al. Among authors: barreto jn. Am J Health Syst Pharm. 2015 Jul 15;72(14):1195-203. doi: 10.2146/ajhp140632. Am J Health Syst Pharm. 2015. PMID: 26150569

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters